
Lithium May Halt Progression of Alzheimer’s Disease
A study at McGill University shows that lithium given in micro doses may be capable of both halting signs of advanced Alzheimer’s pathology and recovering lost cognitive abilities.
A study at McGill University shows that lithium given in micro doses may be capable of both halting signs of advanced Alzheimer’s pathology and recovering lost cognitive abilities.
People with Parkinson’s were given the oral drug rivastigmine (brand name Exelon®). They were 45% less likely to fall and were considerably steadier when walking. Learn more about this dementia drug and fall prevention.
EXCELLENT VIDEO: COMPREHENSIVE, CLEAR, UP-TO-DATE Everything you ever wanted to know about medications & supplements for Alzheimer’s and related dementias.
FDA CommissionerScott Gottlieb NEWS VIDEO + ARTICLE: 17 Alzheimer’s supplement manufacturers received FDA warnings about 58 illegal below-standard products.
OFF-LABEL: An approved prescription drug for high blood pressure is showing promise against Parkinson’s, Huntington’s and other forms of dementia, in experimental studies in the
HELPFUL MEDICATIONS:
Diabetes can increase Alzheimer’s risk. Learn how drug treatments for diabetes bring that risk back down.
HELP FROM THE PHARMACY: Study reveals patients need help managing drugs Community pharmacists could be used more to support patients and carers Assisting carers reduces
MEDICATIONS VIDEO + ARTICLE: Aspirin cleared some Alzheimer’s plaque in the lab. Plaque is the best-known culprit behind Alzheimer’s. Learn about this potential new role
F18 ALZHEIMER’S SCANS offer powerful diagnostic technology, enabling doctors to “see” Alzheimer’s plaque. At $3000 to $6000 per person, are they worth it?
MEMORY DRUGS for Alzheimer’s can slow heart rates and even trigger fainting. The risk is not always clear to patients. Learn how-and-when to consider side-effects,
VIDEO + ARTICLE: Residential areas with more green space were associated with faster thinking, better attention, and higher overall cognitive function in a federal study. Learn more.
Lecanemab is today’s #1 Alzheimer’s antibody. (Brand name: Leqembi) Washington University researchers found Lecanemab’s adverse events to be rare and manageable in very mild or mild Alzheimer’s.
Alzheimer’s is characterized by an overproduction of free radicals in cells. That’s why incredibly tiny “nanoparticles” of silver, found in supplements, cosmetics and food packaging, worry scientists. Hear their concerns, as well as products to avoid.
Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?
Enjoy this great duet between a musician with dementia and his son. A triumph of spirit over Alzheimer’s! Sing-a-long if you like!
It looks like a sneeze cannot give anyone Alzheimer’s. While Alzheimer’s abnormal disease proteins do spread from cell-to-cell, they are not “infectious”. Check out the facts.
No spam, only news and updates.
This site was inspired by my Mom’s autoimmune dementia.
It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. It has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.
The site is dedicated to all those preserving the dignity of the community of people living with dementia.
Peter Berger, Editor